A Malaysian herbal medicine, Lemuni Hitam, which is the black-colored heartwood of Diospyros species (Ebenaceae), is used as a tonic in a decoction, although it is said that taking it in large dosage causes toxicity. In the genus Diospyros, naphthalenes and naphthoquinones have been isolated from the fruit, 1,2) stem, 3) root, 4) heartwood, 5, 6) etc., and recently some biological activities such as ichthyotoxicity, germination inhibition, antifungal activity, 2) platelet aggregation inhibition, 7) and antiprotozoal activity 8) were reported. This paper deals with the isolation and structures of three new naphthoquinone and/or naphthalene dimers (lemuninols A-C, 1-3) together with 4,6-dihydroxy-5-methoxy-2-methylnaphthalene (8) and six known monomers from Lemuni Hitam, and their monoamine oxidase (MAO) inhibitory activity. The MAO inhibition of some other quinones is also discussed.
A Malaysian herbal medicine, Lemuni Hitam, which is the black-colored heartwood of Diospyros species (Ebenaceae), is used as a tonic in a decoction, although it is said that taking it in large dosage causes toxicity. In the genus Diospyros, naphthalenes and naphthoquinones have been isolated from the fruit, 1, 2) stem, 3) root, 4) heartwood, 5, 6) etc., and recently some biological activities such as ichthyotoxicity, germination inhibition, antifungal activity, 2) platelet aggregation inhibition, 7) and antiprotozoal activity 8) were reported. This paper deals with the isolation and structures of three new naphthoquinone and/or naphthalene dimers (lemuninols A-C, 1-3) together with 4,6-dihydroxy-5-methoxy-2-methylnaphthalene (8) and six known monomers from Lemuni Hitam, and their monoamine oxidase (MAO) inhibitory activity. The MAO inhibition of some other quinones is also discussed.
Isolation and the Structures MAO inhibition is related to treatment of emotional disturbance such as anti-depression, and to neuroprotection including anti-Parkinson's disease. [9] [10] [11] [12] The ethyl acetate and the methanol extracts of Lemuni Hitam exhibited MAO inhibitory activity (about 60%) at 2.5ϫ10 Ϫ4 g/ml. Both extracts were independently applied to silica gel chromatography, and the fractions showing a similar TLC pattern were combined together to give fr. 1-A to fr. 1-G. By further separation using Sephadex LH-20 and HPLC-ODS, compound 1 was obtained from fr. 1-E, and compounds 2 and 3 from fr. 1-D. These new compounds were named lemuninols A-C, respectively. Fractions 1-A and 1-B gave compounds 4-7 and 8-10, respectively, by application of preparative TLC (silica gel) and HPLC-ODS.
Lemuninol A (1) is a dark-red powder which shows a FeCl 3 positive (reddish-purple) spot on TLC. The molecular formula of C 24 H 20 O 6 (mw 404) was determined by high-resolution (HR)-FAB-MS. 1 H-and 13 C-NMR spectra suggested that 2 had the same C,D-ring as that of 1, although a proton of 8Ј-H was high-field shifted to d 6.17 (dd, Jϭ1.5, 0.7 Hz). The quinone carbonyl carbons were not observed in the 13 C-NMR of 2, but there were two additional aromatic carbons ( Table 1) . The 1 H-NMR signals according to the A, B-ring in 2 were assigned to three aromatic protons at d 6.80 (s) and d 6.81 and 6.96 (each d, Jϭ9.0 Hz), and two hydroxy groups at d 8.48 and 9.55 together with a methyl group and a methoxy group at d 1.99 and d 4.12, respectively, to characterize 4,6-dihydroxy-5-methoxy-2-methyl-naphthalene by 2D-NMR techniques (Fig. 3) . The NOEs between d 6.17 (8Ј-H) and d 6.81 (8-H), 1.99 (2-CH 3 ) and 2.08 (7Ј-CH 3 ) confirmed the dimerized structure of 2.
The spectral data of lemuninol C (3) are very similar to those of 2, except that the molecular ion was 14 mass units higher (m/z 420) in the EI-MS spectrum. The 1 H-and 13 C-NMR indicated an additional methoxy group instead of a hydroxy group at d 9.24 in 2. The 2D-NMRs such as PFG-HMBC shown in Fig. 4 and NOE between H-8Ј and H-8 revealed the structure of 3.
Compounds 4-8 and 9, 10 were estimated to be naphthalenes and naphthoquinones, respectively, by 13 C-NMR, as shown in Table 2 . Among them, compounds 5, 7, 8 and 10 showed reddish-purple color by FeCl 3 on TLC. The substituents and the positions in each compound were determined by 1 H-and 13 C-NMR including 2D-NMR techniques, and the compounds were finally identified to be 4,5-dimethoxy-2-methyl-, 4-hydroxy-5-methoxy-2-methyl-, 1,4,5-trimethoxy-2-methyl-, 4-hydroxy-1,5-dimethoxy-2-methyl-and 4,6-dihydroxy-5-methoxy-2-methyl-naphthalene for 4-8, and 5-methoxy-2-methyl-, and 6-hydroxy-5-methoxy-2-methyl-1,4-naphthoquinone for 9, 10, respectively (Fig. 1) . To the best of our knowledge, 8 has not been reported as a natural product, and 6 is the first isolation from Diospyros sp.
MAO Inhibition of the Isolated Compounds and the Other Quinones A summary of the MAO inhibitory activity of the isolated compounds is shown in Table 3 . Among them, lemuninol A (1) is the most potent, and lemuninols B and C (2, 3) and a naphthoquinone 9 showed weak activity. Lemuninol A (1) has the same C, D-ring as that of 2, and the A,B-chromophore in 1 is the same structure as that of 9.
Comparing between 2 and 3, methylation of 5Ј-OH in D-ring did not affect the activity. The A, B-chromophore in both 2 and 3 is the same as that in the structure of 8 which has no activity. From these data, each monomer part in 1-3 does not seem to be responsible for its full activity.
To obtain some more information on the active structure of 1, simple quinones were tested for their MAO inhibition (Table 4) . Considering the structures of the active quinones, 11, 14, 15, 16 and 18, they have a 2-methyl-1,4-quinone (not hydroquinone like 22) moiety except for benzoquinone (11) itself. The 2-methyl group cannot substitute with aromatized carbons such as 23, and with halogens in 19-21 for MAO inhibition. Some substituents such as an isopropyl group in 17 and a 6-hydroxy group in 10 counteract the inhibition. A methoxy group at the peri-position also seems to reduce the activity in the case of 9. Although some naphthoquinone monomers showed MAO inhibitory activity, the quinone or naphthalene component in 1 did not explain sufficiently the activity of the dimerized compounds, which possibly need some active structure.
Experimental UV spectra were measured on a Hitachi U-3400 spectrometer. EI-MS and HR-FAB-MS spectra were recorded with JEOL JMS AM-20 and JEOL HX-110 A spectrometers, respectively.
1 H-and 13 C-NMR spectra were measured with JEOL JNM-A500 and -A400 spectrometers with tetramethylsilane or a solvent as internal standard. Column chromatography was performed on Sephadex LH-20, BW-127ZH, Nacalai Silica Gel 60 and Chromatorex ODS (100-200 mesh) and TLC by Merck RP-18F254S and Silica Gel 60 F 254 . Sensyu Pak, ODS-4251-S, ODS-5251-N and ODS-Pegasil were used for HPLC.
Materials Lemuni Hitam was collected by Azizi in 1994 and was identified as Diospyros sp. by Satake. The voucher specimen (LNP19409-01) is kept in the Laboratory of Natural Products, Faculty of Pharmaceutical Sciences, Chiba University.
Isolation Lemuni Hitam, 5.41 g, was cut in small pieces and was extracted successively with ethyl acetate and methanol at room temperature. Both extracts (171 mg and 229 mg, respectively) showed MAO inhibitory activity (about 60% inhibition at 2.5ϫ10 Ϫ4 g/ml) and were independently separated by silica gel column chromatography (ch. 1) using n-hexane/acetone as an eluent. Similar fractions from each extract by TLC were combined together to give fr. 1-A to 1-C eluted with n-hexane/acetone 5 : 1, fr. 1-D to 1-F with 2 : 1, and fr. G with methanol. Further separation of fr. 1-E (52 mg) and fr. 1-D (61 mg) was made independently by Sephadex LH-20 column chromatography with methanol (ch. 2, 4) and then by ODS-HPLC with acetonitrile/water 1 : 1 as an eluent (ch. 3, 5). Compound 1, 19 mg, was obtained from the former fraction, and compounds 2 and 3, 19 and 4 mg, respectively, from the latter. By silica gel chromatography (ch. 6) of fr. 1-A, 85 mg, using an eluent of n-hexane/ethyl acetate 5 : 1, fr. 6-B was obtained, which was then separated by preparative TLC (ch. 7) on silica gel with n-hexane/acetone 5 : 2 to give fr. 7-A (38 mg), 7-B (22 mg) and 7-C (2 mg). Fraction 7-A was separated into compounds 4 and 5, 15 and 4 mg, respectively, by ODS-HPLC (ch. 8, 9) with acetonitrile/water 1 : 1, and fr. 7-B to compounds 6 and 7 (each 8 mg). Fraction 1-B was applied to preparative TLC (ch. 10) on silica gel with n-hexane/ethyl acetate 5 : 3, and each fraction was then purified by ODS-HPLC (ch. 11-13) using an eluent of acetonitrile/water 7 : 13 to yield compounds 8 (6 mg), 9 (2 mg) and 10 (11 mg).
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